Cambridge, MA, United States of America

Hareesh Chamarthi

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 8.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Allston, MA (US) (2019 - 2023)
  • Cambridge, MA (US) (2023)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Innovative Contributions of Hareesh Chamarthi in Antibody Development

Introduction

Hareesh Chamarthi is an accomplished inventor based in Allston, Massachusetts, known for his significant contributions to the field of immunotherapy. With a total of three patents, he has made substantial advancements in the development of anti-PD-1 antibodies, which play a critical role in cancer treatment.

Latest Patents

Hareesh Chamarthi's latest patents focus on the innovation of anti-PD-1 antibodies. These antibodies are designed to bind to programmed cell death protein 1 (PD-1), an essential mechanism in the regulation of immune responses. His patents disclose various compositions comprising such antibodies, as well as methods for making and utilizing them effectively in therapeutic applications.

Career Highlights

Hareesh currently works with the PD-1 Acquisition Group, LLC, where he continues to push the boundaries of what is possible in antibody therapy. His expertise and commitment to research have positioned him as a prominent figure in the field, earning him respect and recognition from peers and industry professionals alike.

Collaborations

Throughout his career, Hareesh Chamarthi has collaborated with talented individuals such as Najmia Amirina and Maria Isabel Chiu. These partnerships have contributed to a dynamic work environment, fostering innovation and the exchange of ideas that drive their collective research forward.

Conclusion

Hareesh Chamarthi's work in the development of anti-PD-1 antibodies showcases his dedication to advancing medical science. As he continues to innovate within his field, his contributions hold the potential to significantly impact cancer therapies, bolstering the fight against this pervasive disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…